JAN 03, 2018 08:29 AM PST
Should Nursing Homes Require Flu Shots for Staff and Patients?
WRITTEN BY: Kara Marker
3 1 166

Every year around this time, warnings of flu season reach their peak. Experts estimate that around 200,000 people every year are hospitalized due to flu infection, yet there is a way, thanks to modern medicine, to reduce the risk of flu. Along with simple habits like frequent hand washing and staying away from sick people, the annual flu vaccine can help prevent the spread of flu. Yet, many nursing homes and similar assisted living facilities have a relatively low rate of vaccination for their residents and staff.

In a new survey from the National Poll on Healthy Aging, conducted by the University of Michigan Institute for Healthcare Policy and Innovation, just over two thousand Americans aged between 50 and 80 - a nationally representative sample - were asked about flu vaccination expectations for nursing homes and other long-term care facilities.

According to the poll’s results, almost 75 percent of individuals believe that nursing homes and other long-term care facilities should require their staff to get a flu vaccine. About 60 percent say that all patients should get a flu vaccine, and 70 percent would be less likely to choose a care facility for themselves or for others if one-third or a greater percentage of the facility’s staff did not receive flu shots.

The poll is partially a result of a serious problem that is emerging: nursing homes and other long-term care facilities (68 percent of staff vaccinated) do not meet the same standard of vaccination against the flu as hospitals and other healthcare settings (92 percent of staff vaccinated).

Why is it particularly important for older people to get a flu vaccine? This portion of the population is more susceptible than the younger portion of the population, as the immune system naturally grows weaker with age. Additionally, older people have an increased likelihood of pneumonia and other dangerous complications once infected with flu.

Credit: University of Michigan

Widespread vaccination for the flu (and other infections) also promotes herd immunity, a phenomenon that is important for people with weakened immune systems or immune disorders that prevent them from being healthy enough to receive a flu vaccine. Herd immunity makes it harder for a virus to be transmitted among a population, given a majority of the population is vaccinated against the virus, protecting those who cannot be vaccinated.

Director of the new poll, Preeti Malani, MD, from the University of Michigan Medical School, strongly encourages individuals to ask nursing homes about their vaccination policies.

“Flu and pneumonia are a critical health concern and in recent years have resulted in over 50,000 deaths annually, making it the 8th leading cause of death just behind diabetes," explained Alison Bryant, PhD from AARP, which funded the survey. "Over 80 percent of these deaths were among older adults ages 65 and older. Increasing vaccination rates to increase herd immunity is imperative to the health and lives of our most vulnerable."

Sources: Centers for Disease Control and Prevention (CDC), Michigan Medicine - University of Michigan, Harvard Health Publishing

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 01, 2018
Drug Discovery
MAR 01, 2018
The 24 hour Flu-Killing Drug
A pharmaceutical company, Shinogi, in Japan has developed an experimental drug that may kill the flu virus in as little as 24 hours.
MAR 02, 2018
Cannabis Sciences
MAR 02, 2018
Photoaffinity Probe Developed to Monitor Endogenous Cannabinoid Receptor 2 Expression and Ligand Engagement
Study to develop method for CB2R expression and ligand engagement to further therapeutic research using CB2R agonists for tissue injury and inflammation
APR 14, 2018
APR 14, 2018
A Vaccine for When Cancer Forms from Human Retroviruses
A vaccine to prevent leukemia and other diseases of the immune system caused by a specific viral infection is now a very real idea. A new study from Kyoto
MAY 04, 2018
Clinical & Molecular DX
MAY 04, 2018
New Blood Test Detects Peanut Allergy with 98% Specificity
A new blood test trumps traditional diagnostic methods for determining peanut allergy, the most common allergy for children. From the Medical Research Coun
MAY 14, 2018
MAY 14, 2018
The Immune System's Antibodies Target Multiple Microbes
For the first time, scientists found that antibodies produced by the immune system can target multiple microbes, as opposed to just one type of microbe. Fr
MAY 22, 2018
MAY 22, 2018
Novel PD-L1/TGF-ß Fusion Protein for HPV-Associated Cancers Enters Phase II Clinical Trial
Novel PD-L1/TGF-ß fusion protein for HPV-associated cancers enters phase II clinical trial. Oncology researchers excited about the potential of this bi-functional protein to combat cancer
Loading Comments...